Investors Urged to Act as Deadline Approaches in Semler Scientific Case

As the October 28, 2025 deadline nears, investors in Semler Scientific, Inc. are facing an urgent need to assess their legal options. Faruqi & Faruqi, LLP, a prominent national securities law firm, is actively investigating potential claims on behalf of these investors. If you purchased or acquired shares in Semler Scientific between March 10, 2021, and April 15, 2025, you may have a valid claim against the company for the alleged losses suffered.

James (Josh) Wilson, a partner at Faruqi & Faruqi, emphasizes the importance for investors to reach out to the firm as soon as possible. He is particularly interested in hearing from anyone who may have pertinent information regarding Semler Scientific's operations during this timeframe, including whistleblowers or former employees. With significant developments indicating possible violations of federal securities laws, it’s crucial for affected investors to understand their rights and options moving forward.

The crux of the allegations against Semler Scientific revolves around their failure to disclose material information critical to investors. Reports indicate that Semler did not adequately inform shareholders about an investigation initiated by the United States Department of Justice (DOJ) concerning potential violations of the False Claims Act. This negligence reportedly misled investors and contributed to the significant losses incurred following the disclosure of the DOJ’s involvement.

On February 28, 2025, Semler Scientific submitted its annual report to the SEC, revealing that they had begun settlement discussions with the DOJ but subsequently halted these conversations. This disclosure raised alarms among investors, culminating in a 9% plunge in stock price on the following trading day, a clear indicator of the impact on investor confidence.

As the lead plaintiff in a federal securities class action, anyone who meets the criteria can take an active role in representing the broader class of investors. It is crucial to understand that the ability to share in any potential recovery does not hinge on whether one is appointed as the lead plaintiff or chooses to remain an absent class member. Investors should not delay in seeking guidance as the deadline quickly approaches.

Faruqi & Faruqi, LLP has established a strong track record of recovering significant sums for investors since its foundation in 1995. The firm encourages any investors who believe they have suffered losses as a direct result of Semler Scientific's actions to communicate with them. This includes sharing any relevant information regarding the case.

For more information about the ongoing investigation or to explore potential claims against Semler Scientific, interested investors should visit Faruqi & Faruqi's website or contact Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Given the complexities involved, timely action could greatly affect the potential outcomes for investors as they navigate what has become a challenging situation. Stay informed and don’t hesitate to seek support in these matters.

Attention to detail and acting promptly can make a significant difference in the pursuit of justice and financial recovery for investors affected by this case. Don’t wait—reach out today to ensure you are fully aware of your legal rights and options.